Hernando-Herraez, Irene
Evano, Brendan
Stubbs, Thomas https://orcid.org/0000-0002-2990-7381
Commere, Pierre-Henri
Jan Bonder, Marc
Clark, Stephen https://orcid.org/0000-0002-6183-491X
Andrews, Simon
Tajbakhsh, Shahragim https://orcid.org/0000-0003-1809-7202
Reik, Wolf https://orcid.org/0000-0003-0216-9881
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-LABX-73)
Association Française contre les Myopathies (332893)
RCUK | Biotechnology and Biological Sciences Research Council (CBBS/E/B/000C0425)
Article History
Received: 13 November 2018
Accepted: 3 September 2019
First Online: 25 September 2019
Competing interests
: W.R. is a consultant and shareholder of Cambridge Epigenetix. T.S. is CEO of Chronomics. All other authors declare no competing interests.